| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 5.17e-08 | 17 | 125 | 5 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 9.61e-08 | 19 | 125 | 5 | GO:0015373 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.73e-07 | 23 | 125 | 5 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 5.25e-07 | 26 | 125 | 5 | GO:0015296 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.53e-07 | 81 | 125 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | symporter activity | 4.71e-06 | 150 | 125 | 8 | GO:0015293 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 4.72e-06 | 6 | 125 | 3 | GO:0005332 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.97e-06 | 119 | 125 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.18e-05 | 23 | 125 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | POMT2 GBE1 POMT1 UGT1A4 MGAT3 ART1 AGL GALNTL5 B4GALNT2 ALG8 | 1.37e-05 | 288 | 125 | 10 | GO:0016757 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 1.96e-05 | 9 | 125 | 3 | GO:0015185 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 3.08e-05 | 29 | 125 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7A SLC2A8 SLC6A17 ABCA10 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 ATP8A1 SLC17A1 | 4.61e-05 | 477 | 125 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.56e-05 | 211 | 125 | 8 | GO:0016758 | |
| GeneOntologyMolecularFunction | catecholamine binding | 6.54e-05 | 13 | 125 | 3 | GO:1901338 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.59e-05 | 35 | 125 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.02e-04 | 171 | 125 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.03e-04 | 15 | 125 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC2A8 SLC6A17 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 SLC17A1 | 1.04e-04 | 296 | 125 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 1.16e-04 | 3 | 125 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | norepinephrine:sodium symporter activity | 1.16e-04 | 3 | 125 | 2 | GO:0005334 | |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 1.16e-04 | 3 | 125 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7A SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 ATP8A1 SLC17A1 | 1.18e-04 | 301 | 125 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | oxysterol binding | 1.26e-04 | 16 | 125 | 3 | GO:0008142 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.16e-04 | 19 | 125 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | creatine transmembrane transporter activity | 2.31e-04 | 4 | 125 | 2 | GO:0005308 | |
| GeneOntologyMolecularFunction | dopamine:sodium symporter activity | 2.31e-04 | 4 | 125 | 2 | GO:0005330 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | MRC1 CHRNA6 OPN4 GPR18 GALR1 OR11H4 UNC5B OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR CLEC2D PTCH2 B9D1 | 2.76e-04 | 1353 | 125 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 3.84e-04 | 5 | 125 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 7.00e-04 | 28 | 125 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 7.31e-04 | 171 | 125 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | copper chaperone activity | 8.00e-04 | 7 | 125 | 2 | GO:0016531 | |
| GeneOntologyMolecularFunction | dopamine binding | 8.00e-04 | 7 | 125 | 2 | GO:0035240 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 1.06e-03 | 8 | 125 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CHRNA6 ATP7A SLC2A8 SLC6A17 GJB6 FLVCR1 ABCA10 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 ATP8A1 SLC14A1 SLC17A1 CACNA2D3 | 1.10e-03 | 1180 | 125 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CHRNA6 ATP7A SLC2A8 SLC6A17 GJB6 FLVCR1 ABCA10 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 ATP8A1 SLC14A1 SLC17A1 ATG9A CACNA2D3 | 1.11e-03 | 1289 | 125 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | amino acid binding | 1.14e-03 | 73 | 125 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.14e-03 | 125 | 125 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.26e-03 | 190 | 125 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 1.28e-03 | 884 | 125 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.51e-03 | 133 | 125 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.84e-03 | 83 | 125 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.89e-03 | 140 | 125 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.95e-03 | 207 | 125 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.20e-03 | 212 | 125 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 2.46e-03 | 12 | 125 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.62e-03 | 151 | 125 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7A SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 SLC17A1 CACNA2D3 | 2.63e-03 | 465 | 125 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CHRNA6 ATP7A SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 ATP8A1 SLC17A1 CACNA2D3 | 3.05e-03 | 664 | 125 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | carbohydrate binding | 3.41e-03 | 310 | 125 | 7 | GO:0030246 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 3.58e-03 | 49 | 125 | 3 | GO:0048487 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.30e-03 | 105 | 125 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.40e-03 | 16 | 125 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | metallochaperone activity | 5.57e-03 | 18 | 125 | 2 | GO:0016530 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 7.55e-03 | 21 | 125 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 7.55e-03 | 21 | 125 | 2 | GO:0030228 | |
| GeneOntologyBiologicalProcess | hyaloid vascular plexus regression | 1.16e-05 | 8 | 124 | 3 | GO:1990384 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.78e-05 | 208 | 124 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 7.84e-05 | 38 | 124 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | positive regulation of protein O-linked glycosylation | 1.07e-04 | 3 | 124 | 2 | GO:1904100 | |
| GeneOntologyBiologicalProcess | regulation of protein O-linked glycosylation | 1.07e-04 | 3 | 124 | 2 | GO:1904098 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 1.62e-04 | 18 | 124 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.74e-04 | 259 | 124 | 8 | GO:0006836 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.80e-04 | 195 | 124 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 1.92e-04 | 19 | 124 | 3 | GO:0031280 | |
| GeneOntologyBiologicalProcess | epinephrine metabolic process | 2.13e-04 | 4 | 124 | 2 | GO:0042414 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid reuptake | 2.13e-04 | 4 | 124 | 2 | GO:0051936 | |
| GeneOntologyBiologicalProcess | creatine transmembrane transport | 2.13e-04 | 4 | 124 | 2 | GO:0015881 | |
| GeneOntologyBiologicalProcess | anatomical structure regression | 2.24e-04 | 20 | 124 | 3 | GO:0060033 | |
| GeneOntologyBiologicalProcess | norepinephrine metabolic process | 2.61e-04 | 21 | 124 | 3 | GO:0042415 | |
| GeneOntologyBiologicalProcess | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process | 2.61e-04 | 21 | 124 | 3 | GO:1902221 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.62e-04 | 275 | 124 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | embryonic axis specification | 2.70e-04 | 52 | 124 | 4 | GO:0000578 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 2.70e-04 | 52 | 124 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 2.75e-04 | 277 | 124 | 8 | GO:1901617 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | POMT2 ENGASE ATP7A CWH43 POMT1 JAK3 MGAT3 GALNTL5 B4GALNT2 ALG8 | 2.75e-04 | 430 | 124 | 10 | GO:0009100 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.75e-04 | 351 | 124 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 2.90e-04 | 53 | 124 | 4 | GO:0042417 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 3.00e-04 | 22 | 124 | 3 | GO:0051350 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 3.12e-04 | 357 | 124 | 9 | GO:0009101 | |
| GeneOntologyBiologicalProcess | response to nicotine | 4.11e-04 | 58 | 124 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 4.39e-04 | 59 | 124 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | ATP7A SPR CYP39A1 SGPP1 UGT1A4 SLC6A3 LHCGR TH DHCR24 FDXR INSIG2 ALG8 | 4.90e-04 | 641 | 124 | 12 | GO:1901615 |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 4.98e-04 | 26 | 124 | 3 | GO:0060088 | |
| HumanPheno | Decreased facial expression | 4.07e-06 | 151 | 44 | 9 | HP:0004673 | |
| HumanPheno | Abnormal facial expression | 2.13e-05 | 185 | 44 | 9 | HP:0005346 | |
| HumanPheno | Mask-like facies | 3.38e-05 | 109 | 44 | 7 | HP:0000298 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.44e-11 | 18 | 124 | 7 | PS00754 | |
| Domain | SNF | 2.26e-11 | 19 | 124 | 7 | PF00209 | |
| Domain | Na/ntran_symport | 2.26e-11 | 19 | 124 | 7 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.26e-11 | 19 | 124 | 7 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.26e-11 | 19 | 124 | 7 | PS50267 | |
| Domain | CUB_dom | 3.78e-05 | 57 | 124 | 5 | IPR000859 | |
| Domain | PMT_4TMC | 4.37e-05 | 2 | 124 | 2 | PF16192 | |
| Domain | PMT | 4.37e-05 | 2 | 124 | 2 | PF02366 | |
| Domain | PMT_4TMC | 4.37e-05 | 2 | 124 | 2 | IPR032421 | |
| Domain | Glyco_trans_39/83 | 4.37e-05 | 2 | 124 | 2 | IPR003342 | |
| Domain | - | 7.78e-05 | 13 | 124 | 3 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 9.86e-05 | 14 | 124 | 3 | IPR000562 | |
| Domain | FN2_2 | 9.86e-05 | 14 | 124 | 3 | PS51092 | |
| Domain | FN2_1 | 9.86e-05 | 14 | 124 | 3 | PS00023 | |
| Domain | fn2 | 9.86e-05 | 14 | 124 | 3 | PF00040 | |
| Domain | FN2 | 9.86e-05 | 14 | 124 | 3 | SM00059 | |
| Domain | GPCR_Rhodpsn_7TM | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 1.46e-04 | 670 | 124 | 14 | IPR017452 |
| Domain | 7tm_1 | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 1.62e-04 | 677 | 124 | 14 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 1.83e-04 | 685 | 124 | 14 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 2.01e-04 | 691 | 124 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | OPN4 GPR18 GALR1 OR11H4 OR2L5 GPR87 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C GPR61 LPAR6 APLNR | 2.04e-04 | 692 | 124 | 14 | IPR000276 |
| Domain | Ldl_recept_a | 2.23e-04 | 45 | 124 | 4 | PF00057 | |
| Domain | - | 2.43e-04 | 46 | 124 | 4 | 4.10.400.10 | |
| Domain | GlyclTrfase_39-like | 2.60e-04 | 4 | 124 | 2 | IPR027005 | |
| Domain | LDLRA_1 | 2.87e-04 | 48 | 124 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.11e-04 | 49 | 124 | 4 | IPR002172 | |
| Domain | LDLa | 3.11e-04 | 49 | 124 | 4 | SM00192 | |
| Domain | LDLRA_2 | 3.11e-04 | 49 | 124 | 4 | PS50068 | |
| Domain | TRYPSIN_SER | 3.33e-04 | 90 | 124 | 5 | IPR033116 | |
| Domain | CUB | 3.37e-04 | 50 | 124 | 4 | SM00042 | |
| Domain | - | 3.92e-04 | 52 | 124 | 4 | 2.60.120.290 | |
| Domain | CUB | 4.21e-04 | 53 | 124 | 4 | PS01180 | |
| Domain | - | 4.71e-04 | 97 | 124 | 5 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 5.17e-04 | 99 | 124 | 5 | IPR016186 | |
| Domain | TRYPSIN_HIS | 6.20e-04 | 103 | 124 | 5 | IPR018114 | |
| Domain | - | 6.45e-04 | 6 | 124 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 6.45e-04 | 6 | 124 | 2 | IPR016071 | |
| Domain | TRYPSIN_SER | 7.06e-04 | 106 | 124 | 5 | PS00135 | |
| Domain | CTDL_fold | 7.37e-04 | 107 | 124 | 5 | IPR016187 | |
| Domain | TRYPSIN_HIS | 7.37e-04 | 107 | 124 | 5 | PS00134 | |
| Domain | SRCR_2 | 8.98e-04 | 7 | 124 | 2 | PF15494 | |
| Domain | Peptidase_S1A | 9.43e-04 | 113 | 124 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.02e-03 | 115 | 124 | 5 | PS50240 | |
| Domain | Tryp_SPc | 1.10e-03 | 117 | 124 | 5 | SM00020 | |
| Domain | Kringle-like | 1.23e-03 | 32 | 124 | 3 | IPR013806 | |
| Domain | Trypsin_dom | 1.28e-03 | 121 | 124 | 5 | IPR001254 | |
| Domain | Trypsin | 1.28e-03 | 121 | 124 | 5 | PF00089 | |
| Domain | Peptidase_S1_PA | 1.38e-03 | 123 | 124 | 5 | IPR009003 | |
| Domain | MIR | 1.90e-03 | 10 | 124 | 2 | PF02815 | |
| Domain | MIR_motif | 1.90e-03 | 10 | 124 | 2 | IPR016093 | |
| Domain | MIR | 1.90e-03 | 10 | 124 | 2 | PS50919 | |
| Domain | MIR | 1.90e-03 | 10 | 124 | 2 | SM00472 | |
| Domain | ZP_dom_CS | 1.90e-03 | 10 | 124 | 2 | IPR017977 | |
| Domain | C_TYPE_LECTIN_1 | 1.98e-03 | 80 | 124 | 4 | PS00615 | |
| Domain | LDLR_class-A_CS | 2.36e-03 | 40 | 124 | 3 | IPR023415 | |
| Domain | Lectin_C | 2.37e-03 | 84 | 124 | 4 | PF00059 | |
| Domain | CLECT | 2.37e-03 | 84 | 124 | 4 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 2.48e-03 | 85 | 124 | 4 | PS50041 | |
| Domain | C-type_lectin-like | 2.58e-03 | 86 | 124 | 4 | IPR001304 | |
| Domain | C-type_lectin_CS | 2.90e-03 | 43 | 124 | 3 | IPR018378 | |
| Domain | ZP_2 | 3.78e-03 | 14 | 124 | 2 | PS51034 | |
| Domain | ZP_1 | 3.78e-03 | 14 | 124 | 2 | PS00682 | |
| Domain | TUDOR | 3.78e-03 | 14 | 124 | 2 | PF00567 | |
| Domain | CUB | 4.21e-03 | 49 | 124 | 3 | PF00431 | |
| Domain | - | 4.34e-03 | 15 | 124 | 2 | 3.30.70.960 | |
| Domain | ZP | 4.34e-03 | 15 | 124 | 2 | SM00241 | |
| Domain | ZP_dom | 5.57e-03 | 17 | 124 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 5.57e-03 | 17 | 124 | 2 | PF00100 | |
| Domain | 7TM_GPCR_Srsx | 6.62e-03 | 112 | 124 | 4 | SM01381 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.12e-07 | 19 | 104 | 5 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.12e-07 | 19 | 104 | 5 | MM15107 | |
| Pathway | WP_NRF2_PATHWAY | SLC2A8 SLC6A17 UGT1A4 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 | 9.52e-07 | 141 | 104 | 9 | M39454 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.01e-05 | 76 | 104 | 6 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.56e-05 | 84 | 104 | 6 | M27334 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 6.17e-05 | 11 | 104 | 3 | M27681 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 6.17e-05 | 11 | 104 | 3 | MM15402 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.91e-05 | 186 | 104 | 8 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.28e-04 | 260 | 104 | 9 | M39397 | |
| Pathway | WP_GPCRS_NONODORANT | 1.53e-04 | 266 | 104 | 9 | MM15843 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | OPN4 GPR18 GALR1 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C LPAR6 APLNR | 1.60e-04 | 330 | 104 | 10 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | OPN4 GPR18 GALR1 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C LPAR6 APLNR | 1.73e-04 | 333 | 104 | 10 | MM14963 |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 2.94e-04 | 18 | 104 | 3 | MM15577 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.75e-04 | 238 | 104 | 8 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.07e-04 | 249 | 104 | 8 | M5988 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | SLC2A8 SLC6A17 UGT1A4 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 | 5.18e-04 | 314 | 104 | 9 | M39428 |
| Pathway | KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK | 5.31e-04 | 5 | 104 | 2 | M47610 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.77e-04 | 52 | 104 | 4 | M14171 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | OPN4 GPR18 GALR1 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C LPAR6 APLNR PTCH2 | 6.07e-04 | 463 | 104 | 11 | M507 |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 7.93e-04 | 6 | 104 | 2 | MM14946 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 7.97e-04 | 25 | 104 | 3 | M27857 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 9.03e-04 | 272 | 104 | 8 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | OPN4 GPR18 GALR1 GPR183 LTB4R2 F2RL1 LHCGR ADRA2C LPAR6 APLNR | 1.27e-03 | 430 | 104 | 10 | MM15160 |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 9.12e-13 | 21 | 129 | 7 | 16125675 | |
| Pubmed | 3.73e-08 | 10 | 129 | 4 | 21148012 | ||
| Pubmed | Modulation of olfactory bulb tyrosine hydroxylase and catecholamine transporter mRNA by estrogen. | 4.99e-08 | 3 | 129 | 3 | 12480184 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 5.93e-07 | 130 | 129 | 7 | 19874574 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | LRP12 ATP7A TMEM248 SLC6A17 POMT1 TXNDC5 FDXR WDR20 ITSN2 SEC24B ALG8 ATG9A TARBP1 | 2.96e-06 | 719 | 129 | 13 | 35337019 |
| Pubmed | 3.45e-06 | 28 | 129 | 4 | 19352218 | ||
| Pubmed | An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye. | 4.12e-06 | 9 | 129 | 3 | 30936473 | |
| Pubmed | 5.01e-06 | 179 | 129 | 7 | 18577758 | ||
| Pubmed | Phenotypic analysis of mice lacking the Tmprss2-encoded protease. | 1.07e-05 | 12 | 129 | 3 | 16428450 | |
| Pubmed | Physical and functional association of human protein O-mannosyltransferases 1 and 2. | 1.37e-05 | 2 | 129 | 2 | 16698797 | |
| Pubmed | POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study. | 1.37e-05 | 2 | 129 | 2 | 18513969 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 1400419 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16887026 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 28512129 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 14699049 | ||
| Pubmed | Norepinephrine transporter and alpha(2c) adrenoceptor allelic variants and personality factors. | 1.37e-05 | 2 | 129 | 2 | 12210281 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18201550 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11093780 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27615543 | ||
| Pubmed | Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2. | 1.37e-05 | 2 | 129 | 2 | 21782786 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22712725 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26786096 | ||
| Pubmed | Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2. | 1.37e-05 | 2 | 129 | 2 | 19880378 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 20700532 | ||
| Pubmed | A role for cortical dopamine in the paradoxical calming effects of psychostimulants. | 1.37e-05 | 2 | 129 | 2 | 35210489 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31520365 | ||
| Pubmed | Dopamine dependency for acquisition and performance of Pavlovian conditioned response. | 1.37e-05 | 2 | 129 | 2 | 24550305 | |
| Pubmed | POMT1 and POMT2 gene mutations result in 2 cases of alpha-dystroglycanopathy. | 1.37e-05 | 2 | 129 | 2 | 34565739 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11784783 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15763138 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23647001 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12193195 | ||
| Pubmed | Substrate-Na+ complex formation: coupling mechanism for gamma-aminobutyrate symporters. | 1.37e-05 | 2 | 129 | 2 | 19450549 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21149640 | ||
| Pubmed | 1.39e-05 | 13 | 129 | 3 | 25127144 | ||
| Pubmed | 1.63e-05 | 143 | 129 | 6 | 20424473 | ||
| Pubmed | 2.69e-05 | 16 | 129 | 3 | 19693267 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 33932356 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 18490429 | ||
| Pubmed | EBI2, GPR18 and GPR17--three structurally related, but biologically distinct 7TM receptors. | 4.09e-05 | 3 | 129 | 2 | 21261596 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 12401330 | ||
| Pubmed | Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. | 4.09e-05 | 3 | 129 | 2 | 29175673 | |
| Pubmed | Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. | 4.09e-05 | 3 | 129 | 2 | 16417582 | |
| Pubmed | Dopaminergic regulation of vestibulo-cerebellar circuits through unipolar brush cells. | 4.09e-05 | 3 | 129 | 2 | 35476632 | |
| Pubmed | POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies. | 4.09e-05 | 3 | 129 | 2 | 20816175 | |
| Pubmed | An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system. | 4.09e-05 | 3 | 129 | 2 | 33608268 | |
| Pubmed | Parallel descending dopaminergic connectivity of A13 cells to the brainstem locomotor centers. | 4.09e-05 | 3 | 129 | 2 | 29789702 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 15955449 | ||
| Pubmed | Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). | 4.09e-05 | 3 | 129 | 2 | 17955457 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 24842606 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 22396544 | ||
| Pubmed | Dopamine pathways mediating affective state transitions after sleep loss. | 4.09e-05 | 3 | 129 | 2 | 37922904 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 19482066 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 22820193 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 19142237 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 15946904 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 22564125 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 28454051 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 23345593 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 23959937 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 34580198 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 34592157 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 22223368 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 23306080 | ||
| Pubmed | Developmental expression of the neurotransmitter transporter GAT3. | 4.09e-05 | 3 | 129 | 2 | 10348670 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 16712949 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 18690111 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 9037545 | ||
| Pubmed | Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. | 4.09e-05 | 3 | 129 | 2 | 24297939 | |
| Pubmed | Considerations when using cre-driver rodent lines for studying ventral tegmental area circuitry. | 4.09e-05 | 3 | 129 | 2 | 25611514 | |
| Pubmed | 6.31e-05 | 21 | 129 | 3 | 17670789 | ||
| Pubmed | 7.29e-05 | 22 | 129 | 3 | 27407143 | ||
| Pubmed | 7.29e-05 | 22 | 129 | 3 | 20035737 | ||
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 1703205 | ||
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 31644913 | ||
| Pubmed | Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 and TAUT/Slc6a6. | 8.15e-05 | 4 | 129 | 2 | 30270321 | |
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 17456771 | ||
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 30210305 | ||
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 11343649 | ||
| Pubmed | Dorsal Raphe Dopamine Neurons Represent the Experience of Social Isolation. | 8.15e-05 | 4 | 129 | 2 | 26871628 | |
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 22961549 | ||
| Pubmed | Profound neuronal plasticity in response to inactivation of the dopamine transporter. | 8.15e-05 | 4 | 129 | 2 | 9520487 | |
| Pubmed | Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. | 8.15e-05 | 4 | 129 | 2 | 14980210 | |
| Pubmed | Mest/Peg1 Is Essential for the Development and Maintenance of a SNc Neuronal Subset. | 8.15e-05 | 4 | 129 | 2 | 28133444 | |
| Pubmed | Optogenetic Activation of A11 Region Increases Motor Activity. | 8.15e-05 | 4 | 129 | 2 | 30364230 | |
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 24802380 | ||
| Pubmed | CD4+-mediated colitis in mice is independent of the GPR183 and GPR18 pathways. | 8.15e-05 | 4 | 129 | 2 | 36389671 | |
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 24837458 | ||
| Pubmed | 8.15e-05 | 4 | 129 | 2 | 8420981 | ||
| Pubmed | 8.36e-05 | 23 | 129 | 3 | 26164566 | ||
| Pubmed | 9.83e-05 | 285 | 129 | 7 | 34369648 | ||
| Pubmed | 1.16e-04 | 67 | 129 | 4 | 20398908 | ||
| Pubmed | 1.35e-04 | 300 | 129 | 7 | 19086053 | ||
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 8956109 | ||
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 28742139 | ||
| Pubmed | Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers. | 1.36e-04 | 5 | 129 | 2 | 18197080 | |
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 33536201 | ||
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 26207352 | ||
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 30295607 | ||
| Pubmed | 1.36e-04 | 5 | 129 | 2 | 15383666 | ||
| GeneFamily | Solute carriers | SLC2A8 SLC6A17 FLVCR1 SLC6A2 SLC6A3 SLC6A7 SLC6A8 SLC6A11 SLC6A13 SLC14A1 SLC17A1 | 8.70e-06 | 395 | 97 | 11 | 752 |
| GeneFamily | C-type lectin domain family | 1.16e-04 | 47 | 97 | 4 | 494 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 8.20e-04 | 78 | 97 | 4 | 262 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 1.00e-03 | 9 | 97 | 2 | 430 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | AGPAT5 SLC6A17 PIPOX GBE1 CLDN7 F2RL1 CYP39A1 GGH LHCGR SLC6A13 KIDINS220 ATP8A1 ATXN1 SLC17A1 AGL APLNR CLEC2D CORIN C1S | 9.85e-07 | 905 | 122 | 19 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.33e-08 | 180 | 128 | 8 | 6a777a308fa3160d31eda468db930e71862020b2 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.16e-08 | 187 | 128 | 8 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-07 | 174 | 128 | 7 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.60e-07 | 175 | 128 | 7 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.89e-07 | 176 | 128 | 7 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.20e-07 | 177 | 128 | 7 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.20e-07 | 177 | 128 | 7 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 185 | 128 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.23e-06 | 188 | 128 | 7 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.23e-06 | 188 | 128 | 7 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.23e-06 | 188 | 128 | 7 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 189 | 128 | 7 | 73ee4cfb1057832f700be59b6917dedde3e89880 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 189 | 128 | 7 | a1bda6ed5c52a5d33d229018cb5982cae6305533 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-06 | 189 | 128 | 7 | 31594cc59eb1c5b01407dfd72b1487ecca8bf5ec | |
| ToppCell | COVID-19_Mild-Lymphoid_P|COVID-19_Mild / Disease group, lineage and cell class | 1.27e-06 | 189 | 128 | 7 | 0b3d3bd697e79decae7e21c513fab9da3b2a47c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-06 | 189 | 128 | 7 | c296660061b46e3abae1e7cf29df20274e5a8add | |
| ToppCell | COVID-19_Mild-Lymphoid_P-Plasmablast|COVID-19_Mild / Disease group, lineage and cell class | 1.27e-06 | 189 | 128 | 7 | 254f058850b41a5974a380f3710db7c01a51fb6b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 189 | 128 | 7 | f2daf4889ef98bbefe3e44832618ac102a75b4d9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-06 | 189 | 128 | 7 | 9de17ade3cc3e9cd1394338bd048fb1ce64ac50f | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-06 | 190 | 128 | 7 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-06 | 190 | 128 | 7 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.36e-06 | 191 | 128 | 7 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.36e-06 | 191 | 128 | 7 | 7b4b5d90d1023d03239ed986f273afa734d3124d | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 191 | 128 | 7 | f892f725a32e704cd18fec2f6d1db82993e7e79a | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 1.36e-06 | 191 | 128 | 7 | bcdadf83cb9653f9cc2a281e7c1095fe8f79173c | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 1.41e-06 | 192 | 128 | 7 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 1.41e-06 | 192 | 128 | 7 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 1.41e-06 | 192 | 128 | 7 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-06 | 193 | 128 | 7 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-06 | 193 | 128 | 7 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-06 | 193 | 128 | 7 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 1.46e-06 | 193 | 128 | 7 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-06 | 193 | 128 | 7 | 1b7d17ef85bbe57adfdf68b728978c4d5521a298 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-06 | 193 | 128 | 7 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-06 | 193 | 128 | 7 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B|COVID-19_Severe / Disease, condition lineage and cell class | 1.73e-06 | 198 | 128 | 7 | 1831a777dd996c25f637d551d754ec1b9c23feb2 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 1.79e-06 | 199 | 128 | 7 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class | 1.79e-06 | 199 | 128 | 7 | 46f31aef26c3da7608082f750d743ad54adbc51a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-06 | 154 | 128 | 6 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.61e-06 | 154 | 128 | 6 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 159 | 128 | 6 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | ICU-SEP-Lymphocyte-B-Plasmablast|ICU-SEP / Disease, Lineage and Cell Type | 8.62e-06 | 166 | 128 | 6 | 98ce43e14133418f676f1c88c001add9e28259a7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-06 | 168 | 128 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-06 | 168 | 128 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-06 | 169 | 128 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-06 | 169 | 128 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 174 | 128 | 6 | 3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 175 | 128 | 6 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 175 | 128 | 6 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.28e-05 | 178 | 128 | 6 | 40a280c1e35963dd45d1809a3e85b568344dd1f5 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.28e-05 | 178 | 128 | 6 | 4fe87c713770173336177e3488f7b4a3be54f71b | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-05 | 181 | 128 | 6 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 181 | 128 | 6 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 181 | 128 | 6 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-05 | 182 | 128 | 6 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 183 | 128 | 6 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 184 | 128 | 6 | 14a5288d861260f63fbe0cbea3569cf643e7597e | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 184 | 128 | 6 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | Dendritic_Cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-05 | 185 | 128 | 6 | 952ded6830b5cabf64d153fc2e003e681e4370a2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 186 | 128 | 6 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.69e-05 | 187 | 128 | 6 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 188 | 128 | 6 | b40146ed0af022422e6526116e5897c676ed9d71 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-05 | 188 | 128 | 6 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.80e-05 | 189 | 128 | 6 | 05e8fb483ebb9010cc54b39d78cca960c58c0f01 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.80e-05 | 189 | 128 | 6 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 189 | 128 | 6 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | control-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.80e-05 | 189 | 128 | 6 | 2e4c2618d06120f83cb4887dd3497b81984a8607 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.80e-05 | 189 | 128 | 6 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 191 | 128 | 6 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 191 | 128 | 6 | 44631226f59364098a7dd58058e6970a75441009 | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 1.91e-05 | 191 | 128 | 6 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 191 | 128 | 6 | f00d6824bd138b192a996e9f7de57b235bb24c18 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 191 | 128 | 6 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 192 | 128 | 6 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 1.97e-05 | 192 | 128 | 6 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.97e-05 | 192 | 128 | 6 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 192 | 128 | 6 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.03e-05 | 193 | 128 | 6 | 22684aa2a368211baba79d29379d0bc442830524 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.03e-05 | 193 | 128 | 6 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.09e-05 | 194 | 128 | 6 | b8f05efb16fbed7317019efc3da7f97f81e90972 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 2.09e-05 | 194 | 128 | 6 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-05 | 194 | 128 | 6 | ffba703f61faaac8b4b9a5e46cd335214303de7b | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-05 | 194 | 128 | 6 | 7dbedbdece4271e10134c9338c85cb3e04484c75 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-05 | 194 | 128 | 6 | bd2c53fb064edfec76abe56a9ffaced0bda32ab0 | |
| ToppCell | severe-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.15e-05 | 195 | 128 | 6 | 43ff1eed563c647bc5b7b06ffe136210653c3a83 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 196 | 128 | 6 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 196 | 128 | 6 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 196 | 128 | 6 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.27e-05 | 197 | 128 | 6 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 197 | 128 | 6 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-05 | 197 | 128 | 6 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 197 | 128 | 6 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-05 | 197 | 128 | 6 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| ToppCell | MS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class | 2.27e-05 | 197 | 128 | 6 | 1b5ac53297cc557e08b9e8e511c2385a38f56bd6 | |
| ToppCell | severe-Plasmablast|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-05 | 198 | 128 | 6 | 0b1620ad4352ee5d599a72931aaceab4ca407498 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-05 | 198 | 128 | 6 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| Drug | tert-butyl glutaminate | 1.13e-06 | 34 | 125 | 5 | CID003450458 | |
| Drug | doxepin | 2.60e-06 | 40 | 125 | 5 | CID000003158 | |
| Drug | cyanuric acid | 4.82e-06 | 21 | 125 | 4 | CID000007956 | |
| Drug | Ro 41-0960 | 8.87e-06 | 8 | 125 | 3 | CID003495594 | |
| Drug | phenethylamine | 1.32e-05 | 9 | 125 | 3 | ctd:C029261 | |
| Drug | nortriptyline | 1.82e-05 | 59 | 125 | 5 | CID000004543 | |
| Drug | Methamphetamine | 1.88e-05 | 10 | 125 | 3 | DB01577 | |
| Drug | His-pro-dkp | 2.43e-05 | 31 | 125 | 4 | CID000065137 | |
| Drug | Bupropion | 2.99e-05 | 2 | 125 | 2 | DB01156 | |
| Drug | Diethylpropion | 2.99e-05 | 2 | 125 | 2 | DB00937 | |
| Drug | Phenmetrazine | 2.99e-05 | 2 | 125 | 2 | DB00830 | |
| Drug | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | 2.99e-05 | 2 | 125 | 2 | ctd:C552530 | |
| Drug | RTI-4793-14 | 2.99e-05 | 2 | 125 | 2 | CID000192688 | |
| Drug | Ephedra | 3.43e-05 | 12 | 125 | 3 | DB01363 | |
| Drug | M3-5 84 | 3.43e-05 | 12 | 125 | 3 | CID000018840 | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | 3.91e-05 | 69 | 125 | 5 | CID000003172 | |
| Drug | Air Pollutants, Occupational | CRISPLD2 LRP12 AARS1 FLVCR1 ZDHHC16 PEX11B F2RL1 OGG1 TH LPAR6 AGL ITSN2 C2 KLHL8 | 4.56e-05 | 725 | 125 | 14 | ctd:D000395 |
| Drug | sipatrigine | 4.97e-05 | 37 | 125 | 4 | CID000060803 | |
| Drug | pyran | 4.97e-05 | 37 | 125 | 4 | CID000033703 | |
| Drug | benzphetamine | 5.08e-05 | 119 | 125 | 6 | CID000002341 | |
| Drug | debrisoquine | 5.84e-05 | 75 | 125 | 5 | CID000002965 | |
| Drug | UDP-glucose | 6.76e-05 | 247 | 125 | 8 | CID000001166 | |
| Drug | tetrabenazine | 6.79e-05 | 40 | 125 | 4 | CID000006018 | |
| Drug | compound 8b | 7.00e-05 | 15 | 125 | 3 | CID000447695 | |
| Drug | hemicholinium-3 | 7.05e-05 | 78 | 125 | 5 | CID000003585 | |
| Drug | desvenlafaxine | 7.49e-05 | 41 | 125 | 4 | CID000125017 | |
| Drug | trimipramine | 7.96e-05 | 80 | 125 | 5 | CID000005584 | |
| Drug | D-161 compound | 8.94e-05 | 3 | 125 | 2 | ctd:C532102 | |
| Drug | 6-fluorodopamine | 8.94e-05 | 3 | 125 | 2 | CID000122236 | |
| Drug | Mazindol | 8.94e-05 | 3 | 125 | 2 | DB00579 | |
| Drug | ASPAN | 8.94e-05 | 3 | 125 | 2 | CID005475577 | |
| Drug | Methylphenidate | 8.94e-05 | 3 | 125 | 2 | DB00422 | |
| Drug | Duloxetine | 8.94e-05 | 3 | 125 | 2 | DB00476 | |
| Drug | 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | 8.94e-05 | 3 | 125 | 2 | ctd:C569113 | |
| Drug | 1,1-bis(3'-indolyl)-1-(p-anisyl)methane | 8.94e-05 | 3 | 125 | 2 | ctd:C545255 | |
| Drug | Venlafaxine | 8.94e-05 | 3 | 125 | 2 | DB00285 | |
| Drug | 4-fluoroamphetamine | 8.94e-05 | 3 | 125 | 2 | ctd:C040639 | |
| Drug | Sibutramine | 8.94e-05 | 3 | 125 | 2 | DB01105 | |
| Drug | RTI-219 | 8.94e-05 | 3 | 125 | 2 | CID010524711 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine | 8.94e-05 | 3 | 125 | 2 | ctd:C079321 | |
| Drug | 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | 8.94e-05 | 3 | 125 | 2 | ctd:C000592273 | |
| Drug | difluoropine | 8.94e-05 | 3 | 125 | 2 | CID000190851 | |
| Drug | Dexmethylphenidate | 8.94e-05 | 3 | 125 | 2 | DB06701 | |
| Drug | Gaba-Glu | 8.94e-05 | 3 | 125 | 2 | CID000129795 | |
| Drug | 2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine | 8.94e-05 | 3 | 125 | 2 | ctd:C000595926 | |
| Drug | 1,4-diazabicyclo[3.3.1]nonane | 8.94e-05 | 3 | 125 | 2 | CID015140257 | |
| Drug | 5-(2-aminopropyl)benzofuran | 8.94e-05 | 3 | 125 | 2 | ctd:C000608250 | |
| Drug | 4-methoxymethamphetamine | 8.94e-05 | 3 | 125 | 2 | ctd:C060169 | |
| Drug | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 8.94e-05 | 3 | 125 | 2 | ctd:C554181 | |
| Drug | creatine | 9.68e-05 | 193 | 125 | 7 | CID000000586 | |
| Drug | maprotiline | 9.92e-05 | 44 | 125 | 4 | CID000004011 | |
| Drug | Tyramine | 1.04e-04 | 17 | 125 | 3 | ctd:D014439 | |
| Drug | NSC-614616 | 1.04e-04 | 17 | 125 | 3 | CID000000690 | |
| Drug | tetrahydropyran | 1.08e-04 | 45 | 125 | 4 | CID000008894 | |
| Drug | NSC367090 | 1.08e-04 | 45 | 125 | 4 | CID000000427 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1669_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6341_DN | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 2302_UP | |
| Drug | amoxapine | 1.18e-04 | 46 | 125 | 4 | CID000002170 | |
| Drug | P-Q-E | 1.25e-04 | 88 | 125 | 5 | CID011963566 | |
| Drug | AC1Q6SL6 | 1.29e-04 | 47 | 125 | 4 | CID000000198 | |
| Drug | C12063 | 1.31e-04 | 429 | 125 | 10 | CID005282055 | |
| Drug | m-tyramine | 1.47e-04 | 19 | 125 | 3 | CID000011492 | |
| Drug | AC1Q5UBL | 1.57e-04 | 146 | 125 | 6 | CID000005466 | |
| Drug | bumetanide | 1.59e-04 | 209 | 125 | 7 | CID000002471 | |
| Drug | DB04649 | 1.69e-04 | 148 | 125 | 6 | CID005287847 | |
| Drug | ethylphenidate | 1.78e-04 | 4 | 125 | 2 | CID003080846 | |
| Drug | Fluorescent Dyes | 1.78e-04 | 4 | 125 | 2 | ctd:D005456 | |
| Drug | Chlorpheniramine | 1.78e-04 | 4 | 125 | 2 | DB01114 | |
| Drug | c0788 | 1.78e-04 | 4 | 125 | 2 | CID000656692 | |
| Drug | Biogenic Monoamines | 1.78e-04 | 4 | 125 | 2 | ctd:D015306 | |
| Drug | 4-(4-Chlorophenyl)piperidine | 1.78e-04 | 4 | 125 | 2 | CID001203613 | |
| Drug | 2-hydroxytetrahydrofuran | 1.78e-04 | 4 | 125 | 2 | CID000093002 | |
| Drug | 2-(2 aminothiazol-4-yl)acetic acid | 1.78e-04 | 4 | 125 | 2 | CID000034665 | |
| Drug | butriptyline | 1.78e-04 | 4 | 125 | 2 | CID000021771 | |
| Drug | norsalsolinol | 1.78e-04 | 4 | 125 | 2 | CID000036937 | |
| Drug | indatraline | 1.78e-04 | 4 | 125 | 2 | ctd:C418119 | |
| Drug | sodium | CHRNA6 SLC2A8 PIPOX SLC6A2 SLC6A3 SLC6A7 SLC6A11 SLC6A13 TH ART1 ATXN1 SLC17A1 FDXR C2 MMP2 | 2.12e-04 | 944 | 125 | 15 | CID000000923 |
| Drug | AC1L19O6 | 2.25e-04 | 156 | 125 | 6 | CID000025750 | |
| Disease | Glycogen Storage Disease Type III | 1.64e-05 | 2 | 120 | 2 | C0017922 | |
| Disease | Glycogen storage disease | 4.28e-05 | 17 | 120 | 3 | cv:C0017919 | |
| Disease | Dopa-Responsive Dystonia | 4.91e-05 | 3 | 120 | 2 | C1851920 | |
| Disease | pterygium (is_implicated_in) | 4.91e-05 | 3 | 120 | 2 | DOID:0002116 (is_implicated_in) | |
| Disease | Dopa-responsive dystonia | 4.91e-05 | 3 | 120 | 2 | cv:CN221588 | |
| Disease | Cobblestone Lissencephaly | 4.91e-05 | 3 | 120 | 2 | C0431376 | |
| Disease | Brain Diseases | 1.41e-04 | 25 | 120 | 3 | C0006111 | |
| Disease | Bipolar Disorder | 1.50e-04 | 477 | 120 | 9 | C0005586 | |
| Disease | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1 | 1.63e-04 | 5 | 120 | 2 | 236670 | |
| Disease | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 1.63e-04 | 5 | 120 | 2 | cv:C4284790 | |
| Disease | lissencephaly (is_implicated_in) | 1.63e-04 | 5 | 120 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | Walker-Warburg syndrome (is_implicated_in) | 1.63e-04 | 5 | 120 | 2 | DOID:0050560 (is_implicated_in) | |
| Disease | Aortic Rupture | 1.63e-04 | 5 | 120 | 2 | C0003496 | |
| Disease | Aortic Aneurysm, Ruptured | 1.63e-04 | 5 | 120 | 2 | C0741160 | |
| Disease | Glycogen Storage Disease | 1.79e-04 | 27 | 120 | 3 | C0017919 | |
| Disease | Encephalopathies | 1.79e-04 | 27 | 120 | 3 | C0085584 | |
| Disease | Qualitative or quantitative defects of alpha-dystroglycan | 2.43e-04 | 6 | 120 | 2 | cv:C2936406 | |
| Disease | Neointima Formation | 2.43e-04 | 6 | 120 | 2 | C2936381 | |
| Disease | Neointima | 2.43e-04 | 6 | 120 | 2 | C2936380 | |
| Disease | Walker-Warburg syndrome (implicated_via_orthology) | 3.40e-04 | 7 | 120 | 2 | DOID:0050560 (implicated_via_orthology) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 3.58e-04 | 34 | 120 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | Recurrent depression | 5.80e-04 | 9 | 120 | 2 | C0221480 | |
| Disease | Mood Disorders | 6.34e-04 | 168 | 120 | 5 | C0525045 | |
| Disease | Delirium | 7.23e-04 | 10 | 120 | 2 | C0011206 | |
| Disease | status epilepticus (biomarker_via_orthology) | 7.55e-04 | 100 | 120 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Heart Diseases | 8.76e-04 | 46 | 120 | 3 | C0018799 | |
| Disease | Gastrointestinal Stromal Sarcoma | 9.33e-04 | 47 | 120 | 3 | C3179349 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 9.72e-04 | 107 | 120 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.05e-03 | 12 | 120 | 2 | C1861063 | |
| Disease | Congenital muscular dystrophy | 1.05e-03 | 12 | 120 | 2 | cv:C0699743 | |
| Disease | Gastrointestinal Stromal Tumors | 1.12e-03 | 50 | 120 | 3 | C0238198 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 1.45e-03 | 14 | 120 | 2 | C1836373 | |
| Disease | alpha-Dystroglycanopathies | 1.45e-03 | 14 | 120 | 2 | C2936406 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 1.45e-03 | 14 | 120 | 2 | C0410174 | |
| Disease | Muscle eye brain disease | 1.45e-03 | 14 | 120 | 2 | C0457133 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 1.45e-03 | 14 | 120 | 2 | C4284790 | |
| Disease | diffuse large B-cell lymphoma | 1.45e-03 | 14 | 120 | 2 | EFO_0000403 | |
| Disease | hypertension (is_implicated_in) | 1.53e-03 | 121 | 120 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | Walker-Warburg congenital muscular dystrophy | 1.66e-03 | 15 | 120 | 2 | C0265221 | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.66e-03 | 15 | 120 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Adrenoleukodystrophy, Neonatal | 1.66e-03 | 15 | 120 | 2 | C0282525 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.14e-03 | 17 | 120 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 2.14e-03 | 17 | 120 | 2 | DOID:11984 (is_marker_for) | |
| Disease | iron biomarker measurement, ferritin measurement | 2.68e-03 | 19 | 120 | 2 | EFO_0004459, EFO_0004461 | |
| Disease | type 1 diabetes mellitus | 3.16e-03 | 242 | 120 | 5 | MONDO_0005147 | |
| Disease | epilepsy (biomarker_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | Lewy Body Disease | 3.59e-03 | 22 | 120 | 2 | C0752347 | |
| Disease | urate measurement, bone density | 3.87e-03 | 619 | 120 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.93e-03 | 157 | 120 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.93e-03 | 157 | 120 | 4 | DOID:14330 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPITKFSNCSYGDFW | 361 | Q9UKF5 | |
| CAYLFTPEWLQGINK | 141 | Q8TER5 | |
| FWGCLGFTVLYRQLP | 251 | Q8WWZ4 | |
| FSYDGIWLFPKNQCK | 126 | Q8NHY0 | |
| FRYFAGWCDKIQGST | 551 | Q3SY69 | |
| VCSARAFVGWYNGLP | 151 | P22570 | |
| GPLFKFFFWIGYCNS | 416 | P18825 | |
| EWPFGEYFCQILGAL | 86 | Q14330 | |
| LGSQWGKAPSSIYFC | 436 | Q008S8 | |
| GAGWCIFVYNLSPEA | 281 | Q14576 | |
| VEYPFFVFGQGWSSC | 646 | P54253 | |
| ILCGFYSEPGKFWVS | 751 | Q96MT7 | |
| FWFPLKALQYGTAFG | 956 | Q9Y2Q0 | |
| SWFTCTGAKYFAIPL | 161 | P0C854 | |
| SFLLCVPVQFFGGWY | 716 | Q04656 | |
| KWGFCPDQGYSLFLV | 386 | P08253 | |
| ALYETPTGWKFFGNL | 351 | P36871 | |
| FQGNFGWFPCNYVEK | 801 | Q9NZM3 | |
| FPNWFGLEKCHRFGL | 106 | P52333 | |
| RDYDWPFGTFFCKLS | 91 | P35414 | |
| WCELQTAYGKELPGF | 91 | Q9H790 | |
| GFPGCWKIQIFLFSL | 26 | Q8NGC9 | |
| CVGLYAQWGSGKSFL | 461 | Q9ULH0 | |
| AVGGQFLLCWLPYFS | 291 | Q9BZJ8 | |
| LSGWDYEYGFCLPKT | 326 | P22888 | |
| VPTCGQWLKYFYGTF | 256 | Q9Y561 | |
| WCFTPEGIYFKLVSA | 421 | Q09327 | |
| GFWSEPQSLCYVFGT | 21 | A0A0A0MT76 | |
| FFQVGLVSWGLYNPC | 691 | P06681 | |
| NRWFLAGVTSFGYKC | 981 | P98073 | |
| LYCSGGLRFFWDNKF | 351 | Q14457 | |
| EPGIYAGYFDWKDCL | 776 | Q96KP1 | |
| IECYSINKNSWFFGP | 336 | Q9P2G9 | |
| LVFPFTGIACSYGWV | 206 | Q8NG80 | |
| FVCNYSPKGNWIGEA | 196 | Q9H0B8 | |
| GKPCVFWLSGFFFTQ | 2936 | Q6ZR08 | |
| YFTTRNWPFGDLLCK | 76 | P43657 | |
| ICDNFPYYKNAGIGW | 96 | Q9P0K8 | |
| NKELGNFFRSLWGPY | 296 | O15527 | |
| LYVRSWLPCIFFAGG | 186 | Q9Y5U4 | |
| DAGFGPWYFKFILCR | 101 | Q9BY21 | |
| SLYKQWLFGETGCEF | 131 | Q9UHM6 | |
| ALCAGGWAVNYLPFF | 641 | Q9Y6A1 | |
| WIYGEALCNVLIGFF | 141 | P55085 | |
| YALPTWVLGAFICKF | 96 | P47211 | |
| LWLCVFTPFFKGCVG | 16 | Q15825 | |
| EKGAFTFWSYAIGLP | 61 | O75146 | |
| LYCKEWAPGAEGVFL | 86 | Q04446 | |
| RGFWSEPQSLCYVFG | 86 | B9A064 | |
| LSPLLSGFQFVCGWY | 1731 | Q4AC94 | |
| DYFPVWGTCLGFEEL | 126 | Q92820 | |
| DPSLIWQYFGSAKGF | 206 | Q8IZS8 | |
| GWDTLQGFLLKYDPC | 266 | Q86XJ1 | |
| FYAVPWSCGTLGFLV | 211 | Q15392 | |
| GLKYNFELILFWGPG | 246 | Q7Z3C6 | |
| FLYNGYHLPWVLKCG | 156 | O95452 | |
| GCKSFQWYLDNVFPE | 421 | Q7Z4T8 | |
| KFYAAGLVSWGPQCG | 646 | P09871 | |
| WGSVCFSKVLGPGVY | 1006 | Q9Y5Q5 | |
| SDYGPKAGNIFLCVW | 486 | Q9Y5Y0 | |
| AQYLEKTFGGWVCPG | 516 | Q6GMR7 | |
| AFGSGKFQCPARWFA | 406 | Q9NYL5 | |
| GYCFALAWVAFPLAL | 136 | P54852 | |
| FSVALFAPGWVYECL | 356 | Q8NFI3 | |
| GDYEILYWDIPNGCK | 741 | Q9HC35 | |
| YTCVLGFQVFGVWPE | 771 | Q9HC35 | |
| QKAVCFFGCPPGYRW | 36 | Q30KP8 | |
| PLGLCWPYADGDFFK | 146 | Q8IXS0 | |
| KYCFVYGQDWAPTAG | 31 | Q9UPM9 | |
| YFACDNVLWAGKSGL | 96 | O96011 | |
| VFYIWVGKGCDNNFI | 1166 | O95487 | |
| LGQWLLIYFGFTHCP | 156 | O75880 | |
| PGGYTLQGKWITTFC | 316 | Q8N323 | |
| FGYCPLKFEGSESLW | 206 | P22897 | |
| AWCTAFKFVPGGVYA | 331 | Q9H720 | |
| TVWKICPFFKGVGYA | 126 | P23975 | |
| QDYNPFWCYKGAIGK | 231 | Q9NWD8 | |
| PGTLCLAKYTDGNWY | 1036 | O60522 | |
| GFCAFLGSWLVPFAY | 146 | Q9UKY4 | |
| ISFAKGWGPCYSRQF | 466 | O43541 | |
| AWPLGQAGCKAVYYV | 86 | Q9NPC1 | |
| RPYGAFWLASAFCIF | 436 | Q9NY64 | |
| CFWEGAKLQGGSAYL | 191 | Q9Y6C5 | |
| KSLPWILLGACFIGY | 191 | P32249 | |
| LPYLFAWICGNLAGQ | 306 | Q14916 | |
| LKLGYFPGQCEWIYC | 171 | Q96BP3 | |
| WPLYCLFCFGTELGN | 126 | Q9BX95 | |
| YFGGLLCVCWSPDGK | 261 | Q8TBZ3 | |
| WRFPYLCYKNGGGVF | 76 | P48029 | |
| INVWNICPLFKGLGY | 121 | P48029 | |
| GTCPKGWLYFNYKCL | 956 | Q13018 | |
| GFKPGLYFRACWLFL | 491 | Q99884 | |
| PFKRGLCHAYWAPNF | 271 | Q9BVK2 | |
| NIKYEFGPAIFIGWA | 156 | O95471 | |
| PESWIGFQRKCFYFS | 76 | Q9UHP7 | |
| WTRQFPILGAGECAY | 151 | Q9UHP7 | |
| EGWLPFEGKCYYFSP | 256 | Q6ZS10 | |
| PNKIYGGLFSEDQCW | 81 | Q9BXU1 | |
| SDYCGFLNKTDGPLW | 521 | O75443 | |
| SFPCGWGYIVLNVAA | 171 | Q6YI46 | |
| KISSNWGNPGFTCLY | 341 | Q8TC36 | |
| SYIFFPDALWGKAAC | 226 | A0A1B0GVZ9 | |
| KYWLLPIFSSLGDGC | 276 | Q5W0Z9 | |
| PLEGCGWAFTTSYKL | 211 | Q2QGD7 | |
| WPILSDGCPFKGDSY | 471 | P60852 | |
| LGSWSFGDYFKELAC | 101 | P49588 | |
| SSLCALQPFKGWALY | 156 | P35270 | |
| ANVWRFPYLCYKNGG | 81 | Q01959 | |
| WRFPYLCYKNGGGAF | 56 | Q9NSD5 | |
| FPDGCLGRLWFSVEY | 196 | X6R8R1 | |
| GNVWRFPYLCYKNGG | 71 | P48066 | |
| EQGSPEACWRFYPKF | 1901 | Q9NY15 | |
| FPIATYAFLKGSCKW | 81 | Q5BJF2 | |
| IYFGLWGFNSSLACI | 281 | Q13336 | |
| AFPATQIYFKCNGEW | 71 | Q8IZJ1 | |
| PYNYGCLDNWKVFLG | 321 | Q969W1 | |
| EVVLLFFYAPWCGQS | 126 | Q6PKC3 | |
| GCWLEFPSIYGLKYH | 111 | Q96KM6 | |
| GGPYICKLCGKAFFW | 206 | Q9H7R0 | |
| IAEGITFIKFYAPWC | 336 | Q8NBS9 | |
| FSVGLGNIWRFPYLC | 76 | Q9H1V8 | |
| SYGVSQAFPCFLWLG | 236 | Q9P0Z9 | |
| LPKFWDCFSYGEENL | 1226 | Q13395 | |
| WKYFGFDTNAEGCIL | 26 | O96006 | |
| EGLKWLPLYGCYFAQ | 121 | Q9NUQ2 | |
| YSFGEGPLTCFFWFI | 141 | Q8IU80 | |
| YWFTVEFGLCKQNGE | 401 | P07101 | |
| FFWRYIPCDLDFKGT | 171 | P22310 | |
| GCYDIPNWSALKYAG | 921 | P35573 | |
| YFWRPKGVELCFGIQ | 821 | Q8WXR4 | |
| IWTCLGAPIKGYSFF | 221 | P52961 | |
| TWLKGIGCYAYDTPD | 5341 | P20929 |